253 related articles for article (PubMed ID: 31866573)
1. Presentation, Treatment, and Outcomes of Vulnerable Populations With Esophageal Cancer Treated at a Safety-Net Hospital.
Asokan S; Sridhar P; Qureshi MM; Bhatt M; Truong MT; Suzuki K; Mak KS; Litle VR
Semin Thorac Cardiovasc Surg; 2020 Summer; 32(2):347-354. PubMed ID: 31866573
[TBL] [Abstract][Full Text] [Related]
2. Impact of Race, Insurance Status, and Primary Language on Presentation, Treatment, and Outcomes of Patients with Pancreatic Adenocarcinoma at a Safety-Net Hospital.
Sridhar P; Misir P; Kwak H; deGeus SW; Drake FT; Cassidy MR; McAneny DA; Tseng JF; Sachs TE
J Am Coll Surg; 2019 Oct; 229(4):389-396. PubMed ID: 31212101
[TBL] [Abstract][Full Text] [Related]
3. Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden.
Sridhar P; Bhatt M; Qureshi MM; Asokan S; Truong MT; Suzuki K; Mak KS; Litle VR
Ann Thorac Surg; 2019 May; 107(5):1472-1479. PubMed ID: 30605641
[TBL] [Abstract][Full Text] [Related]
4. Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.
Du KN; Feng L; Newhouse A; Mehta J; Lasala J; Mena GE; Hofstetter WL; Cata JP
Anesth Analg; 2018 Jul; 127(1):210-216. PubMed ID: 29757780
[TBL] [Abstract][Full Text] [Related]
5. Disparities in esophageal cancer: less treatment, less surgical resection, and poorer survival in disadvantaged patients.
Schlottmann F; Gaber C; Strassle PD; Herbella FAM; Molena D; Patti MG
Dis Esophagus; 2020 Mar; 33(2):. PubMed ID: 31076759
[TBL] [Abstract][Full Text] [Related]
6. Racial Disparity in Utilization of High-Volume Hospitals for Surgical Treatment of Esophageal Cancer.
Rehmani SS; Liu B; Al-Ayoubi AM; Raad W; Flores RM; Bhora F; Taioli E
Ann Thorac Surg; 2018 Aug; 106(2):346-353. PubMed ID: 29684373
[TBL] [Abstract][Full Text] [Related]
7. The impact of geriatric nutritional risk index on surgical outcomes after esophagectomy in patients with esophageal cancer.
Kubo N; Sakurai K; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Yashiro M; Ohira M
Esophagus; 2019 Apr; 16(2):147-154. PubMed ID: 30311102
[TBL] [Abstract][Full Text] [Related]
8. Opportunities to Improve Care of Hepatocellular Carcinoma in Vulnerable Patient Populations.
Hoehn RS; Hanseman DJ; Dhar VK; Go DE; Edwards MJ; Shah SA
J Am Coll Surg; 2017 Apr; 224(4):697-704. PubMed ID: 28069526
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
10. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
11. Aggressive surgical resection does not improve survival in operable esophageal squamous cell carcinoma with N2-3 status.
Zheng YZ; Zhao W; Hu Y; Ding-Lin XX; Wen J; Yang H; Liu QW; Luo KJ; Huang QY; Chen JY; Fu JH
World J Gastroenterol; 2015 Jul; 21(28):8644-52. PubMed ID: 26229406
[TBL] [Abstract][Full Text] [Related]
12. Mitigating disparities in breast cancer treatment at an academic safety-net hospital.
Beaulieu-Jones BR; Shewmaker G; Fefferman A; Kenzik K; Zhang T; Drake FT; Sachs TE; Hirsch AE; Merrill A; Ko NY; Cassidy MR
Breast Cancer Res Treat; 2023 Apr; 198(3):597-606. PubMed ID: 36826701
[TBL] [Abstract][Full Text] [Related]
13. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
Levinsky NC; Wima K; Morris MC; Ahmad SA; Shah SA; Starnes SL; Van Haren RM;
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2555-2566. PubMed ID: 31767364
[TBL] [Abstract][Full Text] [Related]
14. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
[TBL] [Abstract][Full Text] [Related]
15. Disparities in survival after trimodality therapy for esophageal adenocarcinoma.
Eng OS; Nelson RA; Konstantinidis I; Chao J; Erhunmwunsee L; Raz DJ; Kim JY
Dis Esophagus; 2018 Sep; 31(9):. PubMed ID: 29534155
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.
Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
Groth SS; Burt BM; Farjah F; Smaglo BG; Sada YH; Sugarbaker DJ; Massarweh NN
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1682-1693.e1. PubMed ID: 30711279
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
Kauppila JH; Wahlin K; Lagergren P; Lagergren J
Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
[TBL] [Abstract][Full Text] [Related]
19. Socioeconomic factors in timing of esophagectomy and association with outcomes.
Chen KA; Strassle PD; Meyers MO
J Surg Oncol; 2021 Dec; 124(7):1014-1021. PubMed ID: 34254329
[TBL] [Abstract][Full Text] [Related]
20. Log odds of positive lymph nodes predicts survival in patients treated with neoadjuvant therapy followed by esophagectomy.
Ye G; Chen Z; Wang L; Hu Z; Bian Y; Yang X; Lu T; Zhan C; Lin Z; Wang Q
J Surg Oncol; 2020 Jun; 121(7):1074-1083. PubMed ID: 32141098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]